Research, development, manufacturing and marketing of recombinant biopharmaceutical products (APIs & FDFs)
Manufacturing operations span across 5 units, 3 dedicated to APIs and 2 dedicated to FDFs, including a new production line for monoclonal antibodies (mAbs)
20,000 m² manufacturing facility
Address: 1098 yuegong Rd, Jinshan Industrial Zone Shanghai China, Asia